Bernie Romanin

Chief Executive Officer and Director

Dr. Robyn A. Lindley

Chief Scientific Officer and Director

 
Kevin Hollingsworth

Chief Financial Officer

B App Sci and Grad Dip Marketing

Bernie Romanin has extensive healthcare experience in Diagnostics, Pharmaceuticals, Healthcare Bioinformatics and Medical Devices gained in Australia and internationally including commercial expertise (sales, marketing and business development) spanning more than 35 years.

During almost a decade in the USA with Chiron, Novartis and Bayer he has directed market development activities to identify, validate and commercialise new opportunities in diagnostics in the areas of Infectious Diseases (Hepatitis and HIV/AIDS), Oncology, Cardiovascular Disease and Metabolic Disorders.

Bernie has significant experience in managing start-up and new market business opportunities particularly in Technology Licensing and Partnerships and broad experience in managing a multi-functional organisation including R&D, sales and marketing, business development and market research.

Richard Rendell

CTO & Director

Dr. Nathan Hall

Senior Scientist

Dr. Jared Mamrot

Bioinformatician

LEGAL

© 2020 GMDx Genomics. All rights reserved.